Melphalan and XPO1 inhibition are synergistic in pre-clinical models of multiple myeloma

被引：0
|
作者：
Turner, Joel G.
Dawson, Jana L.
Sullivan, Daniel M.
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-289
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
289
引用
收藏
页数：4
相关论文
共 50 条
  • [1] The Synergistic Effect of Melphalan and XPO1 Inhibition in Pre-Clinical Models of Multiple Myeloma
    Cui, Yan
    Turner, Joel G.
    Dawson, Jana L.
    Gomez, Juan A.
    Shain, Kenneth H.
    Meads, Mark B.
    Baloglu, Erkan
    Dalton, William S.
    Nishihori, Taiga
    Sullivan, Daniel M.
    BLOOD, 2016, 128 (22)
  • [2] The synergistic effect of melphalan and XPO1 inhibition in preclinical models of multiple myeloma
    Turner, J.
    Bauer, A.
    Dawson, J.
    Gomez, J.
    Nishihori, T.
    Sullivan, D.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E116 - E116
  • [3] The synergistic effect of melphalan and XPO1 inhibition in preclinical models of multiple myeloma
    Turner, Joel G.
    CANCER RESEARCH, 2017, 77
  • [4] Melphalan and XPO1 Inhibitor Combination Therapy for the Treatment of Multiple Myeloma
    Turner, Joel G.
    Dawson, Jana L.
    Grant, Steven
    Shain, Kenneth H.
    Dai, Yun
    Cubitt, Chris
    Baz, Rachid
    Nishihori, Taiga
    Kauffman, Michael
    Shacham, Sharon
    Sullivan, Daniel M.
    BLOOD, 2014, 124 (21)
  • [5] XPO1 Inhibitor Approved for Multiple Myeloma
    Dolgin, Elie
    CANCER DISCOVERY, 2019, 9 (09) : 1150 - 1151
  • [6] AKTing on XPO1 inhibition in AML
    Stefanie Göllner
    Carsten Müller-Tidow
    Nature Cancer, 2022, 3 : 787 - 789
  • [7] XPO1 Inhibition Disrupts Ribosomal Subunits Assembly and Induces Multiple Myeloma (MM) Cell Death
    Tagoug, Ines
    Neri, Paola
    Slaby, Jiri
    Babich, Jacquelyn
    Simms, Justin
    Gratton, Kathy
    Ren, Li
    Bahlis, Nizar J.
    BLOOD, 2013, 122 (21)
  • [8] PRE-CLINICAL APPROACH OF MULTIPLE SIGNAL TRANSDUCTION PATHWAYS INHIBITION IN MULTIPLE MYELOMA
    Ricciardi, M. R.
    Calabrese, E.
    Milella, M.
    Bergamo, P.
    Levi, A.
    De Benedictis, C.
    Foa, R.
    Tafuri, A. Md
    Petrucci, M. T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 141 - 141
  • [9] AKTing on XPO1 inhibition in AML
    Goellner, Stefanie
    Mueller-Tidow, Carsten
    NATURE CANCER, 2022, 3 (07) : 787 - 789
  • [10] Strahlensensibilität durch Inhibition von XPO1 in Zelllinien kolorektaler Karzinome gesteigertRadiation response enhanced by inhibition of XPO1 in preclinical rectal cancer models
    Moritz von Fallois
    Reinhard Depping
    Strahlentherapie und Onkologie, 2016, 192 : 961 - 962
12345